Global Heart-lung Machine Market Insights Forecasts to 2032
- The Global Heart-Lung Machine Market Size was valued at USD 0.55 billion in 2022.
- The market is growing at a CAGR of 6.7% from 2022 to 2032
- The worldwide heart-lung machine market is expected to reach USD 1.05 billion by 2032
- Europe is expected to grow significant during the forecast period.
Get more details on this report -
The Global Heart-Lung Machine Market Size is expected to reach USD 1.05 billion by 2032, at a CAGR of 6.7% during the forecast period 2022 to 2032.
The heart-lung machine, also known as cardiopulmonary bypass (CPB) machine, is a device used during open-heart surgery to temporarily take over the functions of the heart and lungs. It allows surgeons to operate on a still heart by diverting blood away from the heart and lungs, oxygenating it, and returning it to the body. The machine consists of a pump, oxygenator, and various monitoring and control systems. The pump circulates blood throughout the body, while the oxygenator removes carbon dioxide and adds oxygen to the blood. This enables the surgeon to stop the heart, providing a bloodless and motionless field for complex procedures. The heart-lung machine has revolutionized cardiac surgery, making intricate operations possible and saving countless lives by allowing surgeons to repair damaged hearts.
This research report categorizes the market for heart-lung machine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the heart-lung machine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the heart-lung machine market.
Global Heart-lung Machine Market Report Coverage
|Market Size in 2022:||USD 0.55 Billion|
|Forecast Period:||2022 - 2032|
|Forecast Period 2022 - 2032 CAGR:||6.7%|
|2032 Value Projection:||USD 1.05 Billion|
|Historical Data for:||2018 - 2021|
|No. of Pages:||210|
|Tables, Charts & Figures:||126|
|Segments covered:||By Type, By Application, By End-Use, By Region|
|Companies Covered:||Medtronic, Terumo Europe NV, LivaNova, Inc., Getinge, Braile Biomedica, NIPRO, Tianjin Welcome Medical Equipment Co., Ltd., Elite Lifecare, Hemovent GmbH, MERA, Technowood International Pte. Ltd.|
Get more details on this report -
The heart-lung machine market is driven by several factors that contribute to its growth and development, the rising prevalence of cardiovascular diseases globally is a major driver, as it increases the demand for cardiac surgeries and procedures where heart-lung machines are used. The advancements in technology and the continuous development of innovative heart-lung machine systems are driving market growth, as they improve the efficiency, safety, and effectiveness of these devices. Additionally, increasing healthcare expenditure, favorable reimbursement policies, and growing awareness about advanced treatment options for heart diseases are fueling market expansion. Moreover, the aging population and the consequent increase in age-related heart ailments further drive the demand for heart-lung machines. Overall, the growing number of specialized cardiac centers and hospitals performing complex cardiac surgeries contribute to the market's growth as well.
Despite the positive factors driving the heart-lung machine market, there are certain restraints that pose challenges to its growth, the high cost associated with heart-lung machines and their maintenance restricts their widespread adoption, particularly in developing regions. The complexity of operating and maintaining these devices requires specialized training, which can limit their usage in smaller healthcare facilities with limited resources. Additionally, the risk of complications and adverse events associated with heart-lung machine usage is a concern for both patients and healthcare providers. Furthermore, the availability of alternative treatment options such as minimally invasive procedures and pharmaceutical therapies may impact the demand for traditional open-heart surgeries and, consequently, heart-lung machines.
- In 2022, the single roller pump segment accounted for around 56.4% market share
On the basis of the type, the global heart-lung machine market is segmented into single roller pump and double roller pump. The single roller pump segment has emerged as the dominant player in the heart-lung machine market, holding the largest market share. This can be attributed to several factors, single roller pumps offer several advantages over their counterparts, such as ease of use, compact design, and cost-effectiveness. These pumps provide consistent and reliable blood flow during cardiopulmonary bypass procedures, ensuring efficient oxygenation and circulation. The single roller pumps have been widely adopted in various cardiac surgeries due to their compatibility with different types of oxygenators and tubing systems. They offer flexibility in terms of flow rates and are capable of delivering precise control over blood flow. Furthermore, advancements in pump technology have led to the development of enhanced single roller pumps with improved durability, reduced blood trauma, and better air handling capabilities. Overall, these factors have contributed to the significant market share held by the single roller pump segment.
- In 2022, the cardiac surgeries segment dominated with more than 36.7% market share
Based on the application, the global heart-lung machine market is segmented into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and others. The cardiac surgeries segment has emerged as the largest market share holder in the heart-lung machine market. Several factors contribute to its dominant position, the increasing prevalence of cardiovascular diseases worldwide has led to a growing demand for cardiac surgeries. Heart-lung machines are integral to these procedures, as they provide the necessary support to temporarily replace the functions of the heart and lungs. The advancements in surgical techniques and technology have expanded the scope of cardiac surgeries, including complex procedures such as coronary artery bypass grafting (CABG), valve repair/replacement, and heart transplantations. These procedures often require the use of heart-lung machines to ensure patient safety and successful outcomes. Additionally, the presence of well-established cardiac centers and hospitals specializing in cardiac surgeries further drives the demand for heart-lung machines in this segment. Overall, the cardiac surgeries segment holds the largest market share due to the growing need for these procedures and their dependence on heart-lung machine technology.
Regional Segment Analysis of the Heart-lung Machine Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with more than 38.2% revenue share in 2022.
Get more details on this report -
Based on region, North America has emerged as the dominant market for heart-lung machines due to several key factors, the region has a high prevalence of cardiovascular diseases, contributing to a significant demand for cardiac surgeries and procedures where heart-lung machines are essential. Additionally, North America is known for its advanced healthcare infrastructure, with well-established cardiac centers and hospitals equipped with state-of-the-art facilities and technologies. Moreover, the region benefits from extensive research and development activities in the field of cardiac care, leading to continuous innovations in heart-lung machine systems. Furthermore, favorable reimbursement policies and high healthcare expenditure in North America support the adoption of expensive medical devices like heart-lung machines. Overall, these factors have positioned North America as a dominant market player in the heart-lung machine industry.
- In March 2023, LivaNova announced that its Essenz heart-lung machine had acquired FDA 510(k) approval for cardiopulmonary bypass (CPB) surgeries. This machine has superior cable management and components for a smooth user interface and improved clinical results. This regulatory approval aided the corporation in improving its R&D skills and increasing its commercial revenue.
- In April 2021, Getinge AB announced the availability of the HL 40 heart-lung machine in numerous European nations. During difficult cardiac surgical treatments, this equipment ensures regulated circulation of oxygenated blood. This strategic decision enabled the organization to grow its regional reach and consumer base.
The report offers the appropriate analysis of the key organizations/companies involved within the global heart-lung machine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Companies:
- Terumo Europe NV
- LivaNova, Inc.
- Braile Biomedica
- Tianjin Welcome Medical Equipment Co., Ltd.
- Elite Lifecare
- Hemovent GmbH
- Technowood International Pte. Ltd.
Key Target Audience
- Market Players
- Government Authorities
- Consulting and Research Firm
- Venture Capitalists
- Value-Added Resellers (VARs)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global heart-lung machine market based on the below-mentioned segments:
Heart-lung Machine Market, By Type
- Single Roller Pump
- Double Roller Pump
Heart-lung Machine Market, By Application
- Cardiac Surgeries
- Lung Surgeries
- Acute Respiratory Failure Treatment
Heart-lung Machine Market, By End-Use
- Hospitals & Clinics
- Ambulatory Surgical Centers
Heart-lung Machine Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?